Our AI-enabled breast screening scheduling solution, RSViP, has been named a semifinalist for Best New Radiology Software. We’re in great company, with 200 candidates across 14 categories.
PR
21st March 2024
“It’s a lifesaver, it’s a life changer,” says one of the first women in the UK to have her breast cancer picked up by Kheiron Medical’s technology called Mia® An artific...
Read moreAbstract
4th January 2023
Purpose To demonstrate real-world post-market benefit of artificial intelligence (AI) as an extra reader in breast cancer screening (BCS). Method A commercially available AI system...
Read moreAbstract
4th January 2023
Purpose To evaluate the effectiveness and practical implications of a novel workflow of using AI as a supporting reader for the detection of breast cancer in double reading screeni...
Read moreAbstract
4th January 2023
Purpose To demonstrate the importance of using representative data, including unconfirmed cases (neither positive nor negative) to assess recall rate (RR) and avoid obscuring real-...
Read morePR
28th November 2022
NHS Grampian, which provides health and social care services to more than 500,000 people in Scotland, is trialling Kheiron Medical Technologies’ artificial intelligence to help ...
Read morePR
28th November 2022
In October 2021, Gateshead Health Foundation NHS Trust entered into a research agreement with Kheiron Medical Technologies as part of the NHS Artificial Intelligence (AI) in Health...
Read morePR
11th May 2022
Dr. Wendy DeMartini, Dr. Elizabeth Morris, and Dr. Amy Patel are trailblazers at the forefront of introducing innovative breast imaging technologies into clinical practice (London ...
Read morePR
4th May 2022
InHealth, who provide services for North and East Devon NHS Breast Screening, has entered into the research agreement to work with Kheiron Medical Technologies as part of the AI in...
Read morePR
9th March 2022
This AI cancer diagnostics company joins the ranks of Canva, Microsoft, SpaceX, and other winning companies that are changing lives for the better (London – March 9, 20...
Read more